The Ageing and Dementia Research Centre (ADRC) at Bournemouth University currently run a monthly coffee morning for local older people and others interested in ageing and dementia research to socialise and discuss and share feedback on our work. We have received funding from the British Society of Gerontology (BSG) Small Events Fund to run the session on 12th July (11am-2.30pm) at Bournemouth Gateway Building to enable us to build upon our current model and support the development of a team of older people as co-researchers to take forwards research that is a priority for them.
The aim of this event is to:
1. Disseminate the findings of research projects undertaken by Bournemouth University Ageing and Dementia Research Centre to local older people.
2. Discuss concerns of local older people to support development of an ageing and dementia research priority list.
3. Identify older people interested in becoming co-researchers to take forwards ideas from the ageing and dementia research priority list.
To book a place visit www.eventbrite.co.uk/e/future-directions-in-ageing-research-tickets-654816091557
For further information on this event please contact mheward@bournemouth.ac.uk
Funding statement and Disclaimer: This event is supported by funding from British Society of Gerontology’s (BSG) Small Events fund. The views expressed and discussions may not represent the views of the BSG. For more information about the BSG, click here: https://www.britishgerontology.org/











 BU Festival of Social Sciences invite at RNLI
 MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
 Festival of Social Science: Introducing drowning prevention in Bangladesh
 BU PhD student attending HIV conference on scholarship
 ECR Funding Open Call: Research Culture & Community Grant – Apply Now
 MSCA Postdoctoral Fellowships 2025 Call
 ERC Advanced Grant 2025 Webinar
 Horizon Europe Work Programme 2025 Published
 Horizon Europe 2025 Work Programme pre-Published
 Update on UKRO services
 European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease